Psyence Biomedical Ltd. Secures Clinical Research Partnership with Southern Star Research
Psyence Biomedical Ltd. has entered into a significant Master Services Agreement with Southern Star Research Pty Ltd, a renowned provider of contract clinical research services. Under this agreement, signed on May 21, 2025, Southern Star Research will provide clinical research services to support Psyence's business operations in Australia. As part of the agreement, Psyence will act as the local study sponsor for any projects, ensuring adequate clinical trials liability insurance is in place to meet local regulatory requirements. This collaboration aims to advance Psyence's clinical projects effectively and efficiently, leveraging Southern Star's expertise in clinical research.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-053433), on June 11, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。